Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

被引：0
|
作者：
Robert M. Anthenelli
Michael Gaffney
Neal L. Benowitz
Robert West
Thomas McRae
Cristina Russ
David Lawrence
Lisa St. Aubin
Alok Krishen
A. Eden Evins
机构：
[1] University of California,Department of Psychiatry
[2] San Diego,Department of Medicine
[3] Pfizer,undefined
[4] University of California,undefined
[5] University College,undefined
[6] PAREXEL International on behalf of GlaxoSmithKline,undefined
[7] Massachusetts General Hospital and Harvard Medical School,undefined
来源：
Journal of General Internal Medicine | 2019年 / 34卷
关键词：
neuropsychiatric adverse event; smoking cessation medication; varenicline; predictors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：862 / 870
页数：8
相关论文
共 50 条
  • [31] Exercise as a smoking cessation treatment for women: a randomized controlled trial
    Shira Dunsiger
    Jessica A. Emerson
    Michael Ussher
    Bess H. Marcus
    Robert Miranda
    Peter M. Monti
    David M. Williams
    Journal of Behavioral Medicine, 2021, 44 : 794 - 802
  • [32] Adherence to Blended or Face-to-Face Smoking Cessation Treatment and Predictors of Adherence: Randomized Controlled Trial
    Siemer, Lutz
    Brusse-Keizer, Marjolein G. J.
    Postel, Marloes G.
    Ben Allouch, Somaya
    Sanderman, Robbert
    Pieterse, Marcel E.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (07)
  • [33] Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation: A prescription sequence symmetry analysis
    Wang, Yuanyuan
    van Boven, Job F. M.
    Bos, Jens H. J.
    Schuiling-Veninga, Catharina C. M.
    Boezen, H. Marike
    Wilffert, Bob
    Hak, Eelko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 428 - 429
  • [34] Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial
    Ayers, Catherine R.
    Heffner, Jaimee L.
    Russ, Cristina
    Lawrence, David
    McRae, Thomas
    Evins, A. Eden
    Anthenelli, Robert M.
    DEPRESSION AND ANXIETY, 2020, 37 (03) : 247 - 260
  • [35] Sleep-related adverse events of smoking cessation drugs: A network meta-analysis of randomized controlled trials
    Song, Yubin
    Park, Yoon-A
    Lee, Da Hoon
    Yee, Jeong
    Gwak, Hye Sun
    PSYCHIATRY RESEARCH, 2024, 335
  • [36] Electrocardiographic Changes Associated with Smoking and Smoking Cessation: Outcomes from a Randomized Controlled Trial
    Gepner, Adam D.
    Piper, Megan E.
    Leal, Miguel A.
    Fiore, Michael C.
    Baker, Timothy B.
    Stein, James H.
    CIRCULATION, 2012, 126 (21)
  • [37] Electrocardiographic Changes Associated with Smoking and Smoking Cessation: Outcomes from a Randomized Controlled Trial
    Gepner, Adam D.
    Piper, Megan E.
    Leal, Miguel A.
    Asthana, Asha
    Fiore, Michael C.
    Baker, Timothy B.
    Stein, James H.
    PLOS ONE, 2013, 8 (04):
  • [38] Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation Secondary Analysis of the EAGLES Randomized Clinical Trial
    Nollen, Nicole L.
    Ahluwalia, Jasjit S.
    Sanderson Cox, Lisa
    Okuyemi, Kolawole
    Lawrence, David
    Samuels, Larry
    Benowitz, Neal L.
    JAMA NETWORK OPEN, 2021, 4 (01)
  • [39] RANDOMIZED, CONTROLLED TRIAL OF CLONIDINE FOR SMOKING CESSATION IN A PRIMARY CARE SETTING
    FRANKS, P
    HARP, J
    BELL, B
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (21): : 3011 - 3013
  • [40] Increasing smoking cessation care in a preoperative clinic: a randomized controlled trial
    Wolfenden, L
    Wiggers, J
    Knight, J
    Campbell, E
    Spigelman, A
    Kerridge, R
    Moore, K
    PREVENTIVE MEDICINE, 2005, 41 (01) : 284 - 290
12345